SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (5603)2/22/1998 6:17:00 PM
From: blankmind  Read Replies (1) of 23519
 
RT,

1. I'll accept your numbers:
a. 4,800 refills per week
b. 500,000 scripts per year - total

2. Your numbers mean that Vivus can sit back, run one plant, and do close to 250,000 scrips per year in refills.

3. That would probably make Vivus profitable and the envy of the drug industry.

4. My point is that you complain that the reorders aren't high enough. Imagine a raving lunatic complaining that McDonald's isn't serving enough french fries to justify having 2,000 restaurants open in the United States. And that's how you're coming across. If not, then what's your rationale for complaining that the refill rate isn't high enough?

out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News